Artios Pharma Publishes Preclinical Data on The First Selective Small Molecule Polθ Polymerase…
Artios’ small molecule Polθ inhibitor elicits BRCA-gene synthetic lethality and PARP inhibitor synergyGenetic screening reveals biomarkers within the PARP inhibitor resistance setting to enable patient stratification in clinical…